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Wednesday, February 19, 2014 723athe blocked state of thin filament regulation. Because it has also been shown to
stabilize the closed-state position of tropomyosin, we hypothesized that cTnI-
Md is involved in the cooperativity of thin filament activation. To test this hy-
pothesis, we generated the truncation mutant cTnI(1-167) from R.norvegicus
wherein the entire cTnI-Md had been removed. We used passive exchange to
incorporate cTnI(1-167) and FRET labeled cTnC(T13C/N51C)AEDENS-DDPM
into left ventricular detergent skinned myocardial fibers. SDS-PAGE and
Western blotting demonstrated that cTnC(T13C/N51C)AEDENS-DDPM and
cTnI(1-167) were efficiently exchanged into skinned fibers. Intriguingly, incor-
poration of cTnI(1-167) resulted in biphasic Ca2þ dependent thin filament
activation as indicated by the tightly coupled forceCa2þ and N-cTnC-open-
ing-Ca2þ relationships. Simultaneous force and FRET measurements showed
that treatment with 1 mM orthovanadate inhibited force, reduced ensemble-
averaged N-cTnC opening, and decreased the Ca2þ-sensitivity of activation,
but did not affect the cooperativity underlying the biphasic response of
N-cTnC opening to increasing Ca2þ. Akaike information criteria indicated
that a weighted sum of two Hill equations was>109-fold superior in describing
biphasic activation than a single Hill equation. Interestingly, a steady-state
cooperativity model based on the concept of tropomyosin being "pinned" by
cTnI (J. Mol. Biol., vol. 340, pp. 295-305) was 41-fold superior to the weighted
sum of two Hill equations and suggested that blocked-state allosteric commu-
nication is severely disrupted by removal of cTnI-Md. We concluded that cTnI-
Md helps facilitate allosteric communication between thin filament regulatory
units in the blocked state and is therefore essential to achieving a proper con-
tractile response to sarcomeric Ca2þ signals during early systole.
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The troponin complex is a critical molecular switch involved in transducing
the calcium activating signal into contraction. Troponin I (TnI), the inhibitory
subunit of the complex, is phosphorylated as a key regulatory mechanism to
alter the calcium regulation of contraction. Altered cardiac contraction is a
hallmark of heart failure with several studies demonstrating increased myofi-
brillar calcium sensitivity. Recent work has identified a novel phosphorylation
of TnI at Tyr-26 that is decreased in heart failure with unknown functional
effects. Similar to the location of the desensitizing TnI Ser-23/24 phosphoryla-
tion, TnI Tyr-26 is located in the unique cardiac TnI N-terminal extension.
These data lead us to hypothesize that the N-terminal Tyr-26 phosphorylation
of TnI decreases calcium sensitivity of the thin filament, the loss of which may
contribute to the altered calcium sensitivity observed in heart failure. To assess
the regulatory effects of Tyr-26 phosphorylation, we employed recombinant
human cardiac TnI containing phosphate at Tyr-26 induced by treatment
with a tyrosine kinase and TnI Tyr-26 phosphomimetic substitutions (Glu or
Asp). The effect of TnI Tyr-26 phosphorylation on myofilament calcium
sensitivity was assessed by measuring calcium binding to troponin C (TnC)
in reconstituted thin filaments. Results demonstrate both Tyr-26 phospho-
rylation and phosphomimetics decrease calcium binding to TnC compared to
filaments reconstituted with non-phosphorylated TnI. To further investigate
the effects of TnI Tyr-26 phosphorylation on myofilament deactivation we
measured the rate of calcium disassociation from TnC. Results demonstrate
filaments containing either Tyr-26 phosphorylated TnI or phosphomimetics
increase the rate of calcium dissociation from TnC. Our findings suggest that
TnI Tyr-26 phosphorylation functions similarly to Ser-23/24 N-terminal phos-
phorylation to decrease myofilament calcium sensitivity and increase myofila-
ment relaxation. The loss of TnI Tyr-26 phosphorylation may therefore
contribute to altered cardiac contraction in heart failure.
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Mutations in human cardiac troponin I (cTnI) have been associated with
restrictive, dilated and hypertrophic cardiomyopathies. The most commonly
occurring residue on cTnI that is associated with familial hypertrophic cardio-
myopathy (FHC) is arginine, which is also the most common residue at which
multiple mutations occur. Two FHC mutations are known to occur at arginine
204, R204C and R204H, and both are associated with poor clinical prognosis.
To determine the effect of these mutations (R204C and R204H), as well as
other cTnI mutations, R204P, R204Q, and R204W, calcium-force measure-
ments and cTnI:troponin C (TnC) and cTnI:troponin T (TnT) interactions using
the mammalian two-hybrid luciferase assays were utilized. All five mutationsshowed significant increases in calcium sensitivity of force development
ranging from DpCa50 0.23 (R204W) to 0.35 (R204P). The mutations associ-
ated with FHC, R204C and R204H, had DpCa50 values of 0.28 and 0.29
respectively. The cTnI containing the R204P mutation showed the weakest
interaction with TnT when compared to wild-type cTnI or the other mutants.
The R204H mutation also showed significant impairment in its ability to
interact with TnT, while the R204C mutation showed mild impairment when
compared to wild-type cTnI. The R204C and R204P mutations showed the
greatest impairment in binding to TnC. These results suggest that mutations
at the same site on cTnI could affect thin filament interactions differentially,
and that significant impairment in the interaction of cTnI with TnT or TnC
may be enough to cause significant changes in calcium sensitivity. If the large
increase in calcium sensitivity of force development observed with these mu-
tations is associated with the poor prognosis then other R204 mutations are
likely to have a poor prognosis. This research was supported by a Hellman
Fellowship.
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Recently, the TNNC1 gene that encodes cardiac troponin C (cTnC) was found
as a target for many hypertrophic cardiomyopathy (HCM) mutations in hu-
mans, eliciting alterations in the Ca2þ binding properties of the N-domain of
cTnC. We genetically engineered knock-in mice containing the HCM-
associated A8V mutation in cTnC (heterozygote = KI-TnC-A8Vþ/-; homozy-
gote = KI-TnC-A8Vþ/þ) in order to characterize its in vivo, molecular and
cellular effects. ECHO revealed that at 3 months old (mo) KI-TnC-A8Vþ/þ
mice display increased IVRT and E/A ~1 compared toWT, suggesting diastolic
dysfunction; whereas KI-TnC-A8Vþ/- showed signs of cardiac restriction at 14
mo. Histopathology of both genotyped hearts revealed papillary muscle hyper-
trophy, interstitial fibrosis, and myofibrilar disarray. Real-time PCR analysis at
3 mo demonstrated increases in BNP, a-MHC and b-MHC mRNA levels in the
right ventricles of the KI-TnC-A8V mice (only ANP increased in the left
ventricle). We identified in intact KI-TnC-A8Vþ/- and KI-TnC-A8Vþ/þ cardi-
omyocytes: a significant decrease in the sarcomere length at several stimulation
frequencies; prolonged Ca2þ and contractile transient kinetics at 4Hz; uncou-
pling between Ca2þ decay (delayed) and contractile (no change) transients at
6Hz; suggesting a mechanical frequency-dependent uncoupling from the
Ca2þ transient. Furthermore, a decrease in the baseline Ca2þ fluorescence
and in Ca2þ peak percentage was also detected in KI-TnC-A8Vþ/- and KI-
TnC-A8Vþ/þ, indicating increased myofilament Ca2þ buffering. The calcium
sensitivity of contraction in skinned fibers increased in a gene dose fashion:
KI-TnC-A8Vþ/þ > KI-TnC-A8Vþ/- > WT. The rate of relaxation in KI-
TnC-A8Vþ/þ cardiac skinned fibers investigated by flash photolysis was found
increased, compared to WT. These results suggest that the A8V mutation in
cTnC increases Ca2þ binding affinity to its N-domain eliciting changes in intra-
cellular Ca2þ homeostasis and cellular mechanical function, ultimately leading
to diastolic dysfunction.
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Familial Hypertrophic Cardiomyopathy (FHC) is characterized by severe
abnormal cardiac muscle growth. The traditional view is that mutations asso-
ciated with FHC result in an increase in Ca2þ-sensitivity of cardiac muscle
contraction; however, recent studies indicate that their pathogenesis may
stem from a diminished response to troponin I phosphorylation. The mutation
L29Q, found in the Ca2þ-sensitive muscle regulatory protein, troponin C, has
been tenuously linked to cardiac hypertrophy. L29Q is in the regulatory domain
